1. Home
  2. CRVS vs JBSS Comparison

CRVS vs JBSS Comparison

Compare CRVS & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.03

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo John B. Sanfilippo & Son Inc.

JBSS

John B. Sanfilippo & Son Inc.

HOLD

Current Price

$85.01

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
JBSS
Founded
2014
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
CRVS
JBSS
Price
$14.03
$85.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$30.17
$109.00
AVG Volume (30 Days)
1.0M
95.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
3.26%
EPS Growth
48.04
N/A
EPS
N/A
4.55
Revenue
N/A
$1,107,246,000.00
Revenue This Year
N/A
$5.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
3.79
52 Week Low
$4.05
$59.07
52 Week High
$26.95
$92.08

Technical Indicators

Market Signals
Indicator
CRVS
JBSS
Relative Strength Index (RSI) 50.71 54.80
Support Level $12.74 $74.42
Resistance Level $14.00 $87.16
Average True Range (ATR) 0.69 2.66
MACD -0.12 0.06
Stochastic Oscillator 49.44 70.85

Price Performance

Historical Comparison
CRVS
JBSS

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About JBSS John B. Sanfilippo & Son Inc.

John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.

Share on Social Networks: